American Oncology Network, Inc. is a microcap healthcare stock trading on the OTCQX, with rising revenue but lagging net income and earnings due to share issuances and one-time costs. I maintain a Buy rating for bold investors, emphasizing the company's growth potential despite current profitability challenges and limited information. The company has shown significant revenue growth and expansion in provider numbers and locations, indicating strong market positioning and future growth prospects.
| Health Care Providers & Services Industry | Healthcare Sector | Mr. Todd Schonherz CEO | OTC PINK Exchange | US0287191029 ISIN |
| US Country | 1,525 Employees | - Last Dividend | - Last Split | 5 May 2021 IPO Date |
American Oncology Network, Inc., established in 2017 and headquartered in Fort Myers, Florida, operates through its subsidiaries to deliver comprehensive oncology services across the United States. The organization is dedicated to offering a range of services geared towards the extensive needs of cancer patients. With its focus on integrating various oncological care services under one umbrella, the company strives to provide not only medical treatments but also supportive care that enhances the patient's quality of life during their treatment journey.